Tanvex BioPharma (TANVF) Q4 2025 Earnings

12NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.04
0.3
0.63
0.96

Details

Expected EPS
N/A
Actual EPS
-0.03541428
Surprise EPS
-0.04
Surprise Percent
+∞%

Description

Tanvex BioPharma (TANVF) has reported earnings of -0.03541428 per share for Q4 2025.

0 Comments

Share your thoughts